2.0
21 Mar 2025
Anonymous employee
Current employee, more than 1 year
Recommend
CEO approval
Business outlook
Pros
Blood based biomarkers are the future in diagnostics and having put all their investment in allowing for the ability to scale with a mass spec pipeline was an excellent move. The science and tech are sound.
Cons
I have never seen a company so small have so much infighting. The amount petty behavior is crazy. People are constantly talking behind each others backs, at all levels. Massive gaps in knowledge in the regulatory, compliance and legal side of things. Either extreme caution or ignorance or both, regularly results in inaction. Squandered tech lead and now competitors have caught up and surpassed us.